Published in Cancer Weekly, February 14th, 2006
According to recent research from the United States, "standard chemotherapeutic drugs, when modified by the frequency and dose of administration, can target angiogenesis. This approach is referred to as antiangiogenic chemotherapy, low-dose chemotherapy, or metronomic chemotherapy."
"This study evaluated the feasibility of 6 months of metronomic chemotherapy, its toxicity and tolerability, surrogate markets of activity, and preliminary evidence of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly